253 related articles for article (PubMed ID: 11840543)
21. PrP(Sc) typing by N-terminal sequencing and mass spectrometry.
Chen SG; Zou W; Parchi P; Gambetti P
Arch Virol Suppl; 2000; (16):209-16. PubMed ID: 11214924
[TBL] [Abstract][Full Text] [Related]
22. The octarepeat region of the prion protein is conformationally altered in PrP(Sc).
Yam AY; Gao CM; Wang X; Wu P; Peretz D
PLoS One; 2010 Feb; 5(2):e9316. PubMed ID: 20195363
[TBL] [Abstract][Full Text] [Related]
23. [Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. Part II].
Zaborowski A
Psychiatr Pol; 2004; 38(2):297-309. PubMed ID: 15307294
[TBL] [Abstract][Full Text] [Related]
24. Absence of protease-resistant prion protein in the cerebrospinal fluid of Creutzfeldt-Jakob disease.
Wong BS; Green AJ; Li R; Xie Z; Pan T; Liu T; Chen SG; Gambetti P; Sy MS
J Pathol; 2001 May; 194(1):9-14. PubMed ID: 11329135
[TBL] [Abstract][Full Text] [Related]
25. In vitro selection of RNA aptamers against cellular and abnormal isoform of mouse prion protein.
Sekiya S; Nishikawa F; Noda K; Kumar PK; Yokoyama T; Nishikawa S
Nucleic Acids Symp Ser (Oxf); 2005; (49):361-2. PubMed ID: 17150783
[TBL] [Abstract][Full Text] [Related]
26. Separation of native prion protein (PrP) glycoforms by copper-binding using immobilized metal affinity chromatography (IMAC).
Müller H; Strom A; Hunsmann G; Stuke AW
Biochem J; 2005 May; 388(Pt 1):371-8. PubMed ID: 15658935
[TBL] [Abstract][Full Text] [Related]
27. Mapping of possible prion protein self-interaction domains using peptide arrays.
Rigter A; Langeveld JP; Timmers-Parohi D; Jacobs JG; Moonen PL; Bossers A
BMC Biochem; 2007 Apr; 8():6. PubMed ID: 17430579
[TBL] [Abstract][Full Text] [Related]
28. Cellular prion proteins of mammalian species display an intrinsic partial proteinase K resistance.
Buschmann A; Kuczius T; Bodemer W; Groschup MH
Biochem Biophys Res Commun; 1998 Dec; 253(3):693-702. PubMed ID: 9918789
[TBL] [Abstract][Full Text] [Related]
29. Characterisation of new monoclonal antibodies reacting with prions from both human and animal brain tissues.
Cordes H; Bergström AL; Ohm J; Laursen H; Heegaard PM
J Immunol Methods; 2008 Sep; 337(2):106-20. PubMed ID: 18657541
[TBL] [Abstract][Full Text] [Related]
30. Guanidine hydrochloride extraction and detection of prion proteins in mouse and hamster prion diseases by ELISA.
Kang SC; Li R; Wang C; Pan T; Liu T; Rubenstein R; Barnard G; Wong BS; Sy MS
J Pathol; 2003 Apr; 199(4):534-41. PubMed ID: 12635145
[TBL] [Abstract][Full Text] [Related]
31. Clusterin solubility and aggregation in Creutzfeldt-Jakob disease.
Freixes M; Puig B; Rodríguez A; Torrejón-Escribano B; Blanco R; Ferrer I
Acta Neuropathol; 2004 Oct; 108(4):295-301. PubMed ID: 15235804
[TBL] [Abstract][Full Text] [Related]
32. Detection, quantification, and glycotyping of prion protein in specifically activated enzyme-linked immunosorbent assay plates.
Triantaphyllidou IE; Sklaviadis T; Vynios DH
Anal Biochem; 2006 Dec; 359(2):176-82. PubMed ID: 17092479
[TBL] [Abstract][Full Text] [Related]
33. Co-existence of scrapie prion protein types 1 and 2 in sporadic Creutzfeldt-Jakob disease: its effect on the phenotype and prion-type characteristics.
Cali I; Castellani R; Alshekhlee A; Cohen Y; Blevins J; Yuan J; Langeveld JP; Parchi P; Safar JG; Zou WQ; Gambetti P
Brain; 2009 Oct; 132(Pt 10):2643-58. PubMed ID: 19734292
[TBL] [Abstract][Full Text] [Related]
34. pH-dependent prion protein conformation in classical Creutzfeldt-Jakob disease.
Zanusso G; Farinazzo A; Fiorini M; Gelati M; Castagna A; Righetti PG; Rizzuto N; Monaco S
J Biol Chem; 2001 Nov; 276(44):40377-80. PubMed ID: 11682490
[TBL] [Abstract][Full Text] [Related]
35. [Molecular bases of prion diseases].
Rać M; Rać M
Ann Acad Med Stetin; 2006; 52(3):5-13. PubMed ID: 17385343
[TBL] [Abstract][Full Text] [Related]
36. Use of a new immunoassay to measure PrP Sc levels in scrapie-infected sheep brains reveals PrP genotype-specific differences.
McCutcheon S; Hunter N; Houston F
J Immunol Methods; 2005 Mar; 298(1-2):119-28. PubMed ID: 15847802
[TBL] [Abstract][Full Text] [Related]
37. Prion protein heterogeneity in sporadic but not variant Creutzfeldt-Jakob disease: UK cases 1991-2002.
Head MW; Bunn TJ; Bishop MT; McLoughlin V; Lowrie S; McKimmie CS; Williams MC; McCardle L; MacKenzie J; Knight R; Will RG; Ironside JW
Ann Neurol; 2004 Jun; 55(6):851-9. PubMed ID: 15174020
[TBL] [Abstract][Full Text] [Related]
38. The Distribution of Prion Protein Allotypes Differs Between Sporadic and Iatrogenic Creutzfeldt-Jakob Disease Patients.
Moore RA; Head MW; Ironside JW; Ritchie DL; Zanusso G; Choi YP; Priola SA
PLoS Pathog; 2016 Feb; 12(2):e1005416. PubMed ID: 26840342
[TBL] [Abstract][Full Text] [Related]
39. Molecular typing of PrPres in human sporadic CJD brain tissue.
Lewis V; Klug GM; Hill AF; Collins SJ
Methods Mol Biol; 2008; 459():241-7. PubMed ID: 18576159
[TBL] [Abstract][Full Text] [Related]
40. Sensitive detection of PrPSc by Western blot assay based on streptomycin sulphate precipitation.
Dong CF; Huang YX; An R; Chen JM; Wang XF; Shan B; Lei YJ; Han L; Zhang BY; Han J; Dong XP
Zoonoses Public Health; 2007; 54(8):328-36. PubMed ID: 17894644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]